LYZ and sarcoidosis: It showed higher sensitivity and specificity than other biomarkers [23–26], including angiotensin converting enzyme (ACE), lysozyme and soluble IL-2 receptor [11, 12] and it has been found increased in active sarcoidosis patients [11] showing to predict clinical course, steroid responsiveness and relapse of the disease [13].